Journal profile · Medicine-Oncology
JCO Global Oncology
ISSN 2687-8941 · American Society of Clinical Oncology · United States
JCO Global Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.7 (journal website); fully open access; APC about USD 2,472; median 130 days to acceptance (101 articles, last 24 months); 274 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JCO Global Oncology is published by American Society of Clinical Oncology and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Advances in Oncology and Radiotherapy and Economic and Financial Impacts of Cancer, together about 36.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JCO GO aims to provide a home for high-quality literature that fulfills a growing need for content describing the array of challenges faced by health care professionals in resource-constrained settings. Article types include original reports, review articles, commentaries, correspondence and replies, special articles and editorials.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Katherine Van LoonPublisher website
Editorial board by country: none in mainland China; most named United States 3, India 1, Canada 1, Australia 1, Türkiye 1 (8 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine18%
- Advances in Oncology and RadiotherapyMedicine10.3%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance8.3%
- Cervical Cancer and HPV ResearchMedicine6.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
- Acute Lymphoblastic Leukemia researchMedicine4%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance3.8%
- Global Health and SurgeryMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6.7Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 30Publisher website ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 50OpenAlex ·
- i10-index
- 454OpenAlex ·
- 2-year mean citedness
- 2.31OpenAlex ·
- Self-citation rate
- 7.9%LetPub ·
- Share of gold OA articles
- 99.82%LetPub ·
Volume
- Articles per year
- 229LetPub ·
- Downloads per year (publisher)
- 2,023Publisher website ·
Articles by year OpenAlex count · 1,906 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 217 | 217 | 71 |
| 2025 | 274 | 274 | 460 |
| 2024 | 402 | 402 | 1,532 |
| 2023 | 325 | 325 | 1,668 |
| 2022 | 210 | 210 | 1,939 |
| 2021 | 194 | 194 | 3,961 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
130 daysMedian, submission to acceptance · P25–P75 88 days – 176 days
- Acceptance to online
- median 57 days (101 articles)
- Submission to online
- median 200 days
- Sample
- 101 articles with submission and acceptance dates (559 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,472 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,472 | — | — | |
| LetPub | USD 2,472 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- American Society of Clinical Oncology
- Country or region
- United States
- Language
- English
- ISSN
- 2687-8941
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JCO Global Oncology
What CAS zone is JCO Global Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, JCO Global Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JCO Global Oncology?
The journal's website gives an impact factor of 6.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.3, h-index 50.
How long does peer review take at JCO Global Oncology?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 130 days (interquartile range 88–176 days); authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JCO Global Oncology?
According to the journal's author guidelines: First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JCO Global Oncology based?
Of the 8 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (3), India (1) and Canada (1). Counted from the institutions listed on the board page; for reference only.
Which databases index JCO Global Oncology?
According to LetPub and DOAJ records, JCO Global Oncology is indexed in ESCI, Scopus and DOAJ.
Is JCO Global Oncology open access, and what is the APC?
JCO Global Oncology is a fully open-access journal. APC about USD 2,472.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .